v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT05132972 |
Full text link
Last imported at : Nov. 25, 2021, 9 p.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : Nov. 25, 2021, 9 p.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : Nov. 25, 2021, 9 p.m. Source : ClinicalTrials.gov |
bjortho@yahoo.com |
Registration date
Last imported at : Nov. 25, 2021, 9 p.m. Source : ClinicalTrials.gov |
2021-11-24 |
Recruitment status
Last imported at : Nov. 25, 2021, 9 p.m. Source : ClinicalTrials.gov |
Recruiting |
Study design
Last imported at : Nov. 25, 2021, 9 p.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : Nov. 25, 2021, 9 p.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : Nov. 25, 2021, 9 p.m. Source : ClinicalTrials.gov |
Parallel |
Masking
Last imported at : Nov. 25, 2021, 9 p.m. Source : ClinicalTrials.gov |
Blind label |
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
multi-center |
Study aim
Last imported at : Nov. 25, 2021, 9 p.m. Source : ClinicalTrials.gov |
Treatment |
Inclusion criteria
Last imported at : Nov. 25, 2021, 9 p.m. Source : ClinicalTrials.gov |
inclusion criteria: man or woman age 18-75 years sars-cov2 positive as confirmed by sars-cov2 rt-pcr test diagnosed with pnumonia as confirmed by chect radiography and history of fever, coug with one of the following symptoms: rr > 30x per minute, sao2 93%, fao2/fio2 300 mmhg voluntarily joined the clinical trial and has signed the informed consent form |
Exclusion criteria
Last imported at : Nov. 25, 2021, 9 p.m. Source : ClinicalTrials.gov |
pregnant and lactating woman patient who are diagnosed or have history of tumor and cancer patient whose mother or sister are diagnosed with breast or ovarian cancer level of sgpt/alt is ≥ 5 times upper limit from normal value level of egfr is < 30 ml/min reluctant to sign informed consent and unwilling to take the required tests require invasive ventilation shock organ failure currently involve in other clinical trial, or join another clinical trial in the last 3 months |
Number of arms
Last imported at : Nov. 25, 2021, 9 p.m. Source : ClinicalTrials.gov |
2 |
Funding
Last imported at : Nov. 25, 2021, 9 p.m. Source : ClinicalTrials.gov |
Kementerian Riset dan Teknologi / Badan Riset dan Inovasi Nasional, Indonesia |
Inclusion age min
Last imported at : Nov. 25, 2021, 9 p.m. Source : ClinicalTrials.gov |
18 |
Inclusion age max
Last imported at : Nov. 25, 2021, 9 p.m. Source : ClinicalTrials.gov |
75 |
Countries
Last imported at : Nov. 25, 2021, 9 p.m. Source : ClinicalTrials.gov |
Indonesia |
Type of patients
Last imported at : Nov. 25, 2021, 9 p.m. Source : ClinicalTrials.gov |
Severe disease at enrollment |
Severity scale
Last imported at : Nov. 25, 2021, 9 p.m. Source : ClinicalTrials.gov |
6: Severe disease at enrollment |
Total sample size
Last imported at : Nov. 25, 2021, 9 p.m. Source : ClinicalTrials.gov |
42 |
primary outcome
Last imported at : Nov. 25, 2021, 9 p.m. Source : ClinicalTrials.gov |
Duration of hospital stay |
Notes
Last imported at : Nov. 25, 2021, 9 p.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : Nov. 25, 2021, 9 p.m. Source : ClinicalTrials.gov |
Phase 2/Phase 3 |
Arms
Last imported at : Nov. 25, 2021, 9 p.m. Source : ClinicalTrials.gov |
[{"arm_notes": "", "treatment_id": 1334, "treatment_name": "Umbilical cord mesenchymal stem cells", "treatment_type": "Advanced therapy medicinal products (atmp)", "pharmacological_treatment": "Biological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}] |